These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 6187766

  • 1. Amine metabolites in the ventricular cerebrospinal fluid of patients with ventricular dilatation. HPLC and clinical application (IV).
    Ikeda Y, Nakazawa S.
    Nihon Ika Daigaku Zasshi; 1982; 49(6):848-50. PubMed ID: 6187766
    [No Abstract] [Full Text] [Related]

  • 2. Monoamine metabolites and ventricular fluid pressure in children.
    Yates CM, Minns RA.
    Childs Brain; 1981; 8(2):138-44. PubMed ID: 6166434
    [Abstract] [Full Text] [Related]

  • 3. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E, Young SN, Lal S, Sourkes TL.
    Brain Res; 1974 Oct 11; 79(1):1-8. PubMed ID: 4279131
    [No Abstract] [Full Text] [Related]

  • 4. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul 11; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 5. Isocratic analysis of 3-methoxy-4-hydroxyphenyl glycol, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with amperometric detection.
    Bottiglieri T, Lim CK, Peters TJ.
    J Chromatogr; 1984 Nov 28; 311(2):354-60. PubMed ID: 6084013
    [No Abstract] [Full Text] [Related]

  • 6. Role of neurotransmitter in forensic medicine (report II). A simple and simultaneous analysis of the major monoamine metabolites in human cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Endo T, Nishida A, Kano S.
    Nihon Hoigaku Zasshi; 1987 Feb 28; 41(1):4-9. PubMed ID: 2439728
    [No Abstract] [Full Text] [Related]

  • 7. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF.
    Psychiatry Res; 1979 Oct 28; 1(2):131-9. PubMed ID: 95232
    [Abstract] [Full Text] [Related]

  • 8. Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
    Mena MA, Aguado EG, de Yebenes JG.
    Acta Neurol Scand; 1984 Apr 28; 69(4):218-25. PubMed ID: 6204498
    [Abstract] [Full Text] [Related]

  • 9. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T, Fujimoto A, Ohshimo T, Yamamoto M, Kugoh T, Akiyama K, Otsuki S.
    No To Shinkei; 1979 Dec 28; 31(12):1225-31. PubMed ID: 93481
    [No Abstract] [Full Text] [Related]

  • 10. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM, Tsementzis SA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1979 Oct 28; 42(10):887-91. PubMed ID: 512664
    [Abstract] [Full Text] [Related]

  • 11. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L, Asberg M, Lantto O, Scalia-Tomba GP, Träskman-Bendz L, Tybring G.
    Psychiatry Res; 1982 Feb 28; 6(1):77-83. PubMed ID: 6173891
    [Abstract] [Full Text] [Related]

  • 12. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R, Ekstedt J, Anggård E.
    J Neurol Neurosurg Psychiatry; 1975 Jul 28; 38(7):666-8. PubMed ID: 1159438
    [Abstract] [Full Text] [Related]

  • 13. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Jul 28; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 14. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 15. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T, Hara S, Kuriiwa F, Kano S.
    Forensic Sci Int; 1990 Jan 12; 44(1):61-8. PubMed ID: 1689267
    [Abstract] [Full Text] [Related]

  • 16. Origins of catecholamine metabolites in monkey cerebrospinal fluid.
    Gordon E, Perlow M, Oliver J, Ebert M, Kopin I.
    J Neurochem; 1975 Sep 12; 25(3):347-9. PubMed ID: 808591
    [No Abstract] [Full Text] [Related]

  • 17. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M, Chang WH, Kirk KL, Linnoila M.
    Anal Biochem; 1983 May 12; 131(1):246-53. PubMed ID: 6193730
    [Abstract] [Full Text] [Related]

  • 18. CSF neurotransmitter studies. An infant with ascorbic acid-responsive tyrosinemia.
    Stoerner JW, Butler IJ, Morriss FH, Howell RR, Seifert WE, Caprioli RM, Adcock EW, Denson SE.
    Am J Dis Child; 1980 May 12; 134(5):492-4. PubMed ID: 6155067
    [Abstract] [Full Text] [Related]

  • 19. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L, Wiberg A, Asberg M, Träskman L, Sjöstrand L, Thorén P, Bertilsson L, Tybring G.
    Psychiatry Res; 1981 Feb 12; 4(1):21-9. PubMed ID: 6164071
    [Abstract] [Full Text] [Related]

  • 20. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 12; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.